Treatment of hyperlipidemia.
D001798:Blood Proteins / Q000032:analysis; D002784:Cholesterol / Q000097:blood; D002792:Cholestyramine Resin / Q000627:therapeutic use; D002914:Chylomicrons / Q000097:blood; D002994:Clofibrate / Q000627:therapeutic use; D003365:Costs and Cost Analysis; D004035:Diet Therapy; D004359:Drug Therapy, Combination; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood / Q000145:classification / Q000188:drug therapy* / Q000378:metabolism / Q000628:therapy; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008074:Lipoproteins / Q000097:blood / Q000378:metabolism; D008075:Lipoproteins, HDL / Q000097:blood; D008077:Lipoproteins, LDL / Q000097:blood; D008079:Lipoproteins, VLDL / Q000097:blood; D009355:Neomycin / Q000627:therapeutic use; D009539:Nicotinic Acids / Q000627:therapeutic use; D010743:Phospholipids / Q000097:blood; D012855:Sitosterols / Q000627:therapeutic use; D013974:Thyroxine / Q000627:therapeutic use; D014280:Triglycerides / Q000097:blood
D001798:Blood Proteins; D002914:Chylomicrons; D000960:Hypolipidemic Agents; D008074:Lipoproteins; D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL; D008079:Lipoproteins, VLDL; D009539:Nicotinic Acids; D010743:Phospholipids; D012855:Sitosterols; D014280:Triglycerides; D002792:Cholestyramine Resin; D002784:Cholesterol; D002994:Clofibrate; D009355:Neomycin; D013974:Thyroxine